The use of intravenous lipid emulsions (ILEs) as antidote in local anesthetic systemic toxicity has gained widespread support following convincing data from animal models, and successful case reports in humans. Аn injection of a simple, intravenous nutritional solution could be acutely life-saving for a patient with severe drug overdose. But dozens of published case reports support this observation, the first ones made more than a decade ago in a rodent model of bupivacaine toxicity. It is even more surprising that such a simple formulation can rapidly reverse severe clinical toxicity from a variety of vastly disparate medications with distinct pharmacodynamics and mechanisms of action. This review will focus on the clinical application of lipid emulsion therapy in resuscitation from drug-related toxicity and will provide an introduction to the development of a method, guidelines for its use, and insights into potential controversies and future applications [1] .
Introduction
Intravenous lipid emulsion (ILE) has a long history of use as a parenteral nutrition formulation in both adult and pediatric patients. ILE also emerged as a new treatment for iatrogenic and intentional poisoning with medications [2] . ILE is a new method for treating systemic toxicity of local anesthetics (LAST), which is an effective antidote for poisoning by other lipophilic drugs. Cardiovascular collapse is the biggest life-threatening complication of absorption of local anesthetics (LA), or intravascular injection, during regional anesthesia [3] . Generally, LAST is deemed to be resistant to conventional methods of resuscitation. As early as 1998 Weinberg and colleagues reported attenuation of bupivacaine toxicity in a rat model [4] , in intact dogs [4] . Earlier findings of lipid modulation of free drug concentrations were reported as far back
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Daniela Chaparoska, University Clinic of Toxicology, "Vodnjanska", 17, 1000 Skopje, R. Macedonia; E-mail: chaparoskadani@gmail.com as 1974. Promising laboratory studies such as these may have forever lacked clinical impact but for two sentinel cases of ILE use in human poisoning. In 2006 Rosenblatt et al. [5] reported successful resuscitation with ILE following bupivacaine and mepivacaine-induced cardiac arrest in a middle-aged man undergoing brachial plexus block. He subsequently recovered completely with no neurologic deficit or cardiovascular sequelae. This case is now recognized as typical of many lipid resuscitation cases and exemplifies key features repeated in virtually every subsequent report of reversal by lipid infusion of LAST-related cardiac arrest: (a) the event was witnessed (meaning, little to no associated asphyxia or delay in treatment); (b) the patient failed to recover with epinephrine, vasopressin, and antiarrhythmic medications; and (c) spontaneous circulation was reestablished shortly after lipid infusion. An additional feature common to many of the early case reports of lipid therapy for severe LAST was the presence of underlying heart disease, suggesting that coronary ischemia, baseline conduction defects, or cardiomyopathy could lower the threshold for LAST, thereby defining one subgroup of vulnerable patients. Likewise in 2007, Sirianni and colleagues [6] published a case of overwhelming bupropion and lamotrigine selfpoisoning in a 17-year-old girl. Cardiovascular collapse refractory to standard resuscitative measures persisted for 70 minutes before administration of 100 ml ILE. Immediately after injection the patient exhibited a sustained stable circulation and survived to hospital discharge. These, the first case reports of successful ILE use in local anesthetic systemic toxicity (LAST) and non-local anesthetic intoxication, respectively, are unique for a number of reasons. In both instances attending physicians were presented with desperate and apparently irretrievable clinical scenarios secondary to poisoning. The decision to employ ILE was made late in the course of resuscitative attempts as a "last gasp" measure, with only limited animal data to support utilisation. And, in both circumstances, use was associated with dramatic success and patient survival. McCutchen and Gerancher [7] reported that in a patient with seizures and ventricular tachycardia following a combined femoral catheter (ropivacaine) and (bupivacaine) block, the use of lipid emulsion early in the sequence of rapidly worsening toxicity appeared to attenuate or prevent progression of local anesthetic cardiac toxicity. This observation suggests that early lipid infusion might provide an advantage, presumably by interrupting the vicious cycle of low-output, tissue acidosis, and worsening toxicity, thereby preventing progression to a low-output state or frank cardiac arrest. Several other recent cases seem to support this notion. These reports contribute directly to the controversy surroundding optimal timing of the lipid emulsion infusion. Successful treatment of severe cardiac toxicity has been reported in children, including two infants, one 2-day-old, and the other 9-day-old. The oldest patient reported with successful lipid resuscitation is a 92-year-old woman in asystole after infraclavicular block ropivacaine. Lipid infusion also can recover neurological signs and symptoms of LAST, including the presence of seizures and altered mental status, which indicates that the benefit is not limited to the cardiovascular system [8, 9] . This likewise contributes to the debate about the mechanisms based on lipid resuscitation: metabolic situation is sustained in the case of neurotoxicity, since the central nervous system usually does not depend on the lipid substrates. More cases of lipid resuscitation of local anesthetic toxicity may be found in recent review studies [10, 1] . Additional cases, along with a description of the use of lipids in the treatment of many other types of drug toxicity, set educational website sites. Although it is assumed that only a fraction of all cases is reported, the hope is that over time, methods will be identified to increase the rate of identifying and reporting cases.
Material and methods
The medical literature was surveyed for articles pertaining to treatment of severe, systemic local anesthetic toxicity. Specifically, the PubMed database was retrieved using combinations of the following search terms: local anesthetic, regional anesthesia, nerve block, toxicity, cardiac arrest, resuscitation, myocardial depression, epinephrine, vasopressin, vasopressor, cardiopulmonary bypass, lipid, lipid rescue, emulsion, bupivacaine, levobupivacaine, mepivacaine, lidocaine, ropivacaine, and etidocaine. Searches were then run with selected limits including human, animal studies, and case reports.
Mechanism
Understanding the mechanism(s) that underlie the effects of lipid emulsion infusion could lead to an improved treatment of drug toxicity and possibly extend the use of lipid resuscitation to other clinical scenarios. The typical solutions used for parenteral nutrition are very complex mixtures of natural (e.g., soy) products, and this complexity might explain the wide spectrum of resulting physiologic and pharmacologic effects. Two effects in particular, partitioning and enhanced metabolism, were initially posited to explain the benefit of lipid infusion during bupivacaine toxicity. However, evidence has recently accumulated indicating several other important potential sites of action.
Lipid Sink Phenomenon
Especially important role has the so-called "lipid sink" in reversal of local anesthetic overdose. Simply stated, the infused intravascular lipid mass binds the offending toxin in sufficient quantity to pull drug from the target tissue, thereby reversing the toxicity. Indirect evidence in support of this theory includes the fact that lipid can reverse both neurologic and cardiac toxicity, though the brain does not metabolize fatty acids as an energy source to an appreciable degree. Furthermore, as noted above, lipid infusion is reported to reverse toxicity caused by an array of drugs lacking a common mechanism, site of action, chemical structure, or clinical effect (e.g., calcium channel blockers, B-blockers, typical and atypical antipsychotics, tricyclic and other antidepressants, local anesthetics, and parasiticides, among others).
Cardiotonic effect
While clinical and experimental effects spanning agents and organ systems favor a pharmacokinetic mechanism as important in the action of ILE, they are not a complete explanation. Recent data suggest that lipid emulsions at the doses used have direct cardiotonic effects. Experimentally, rats infused with lipid emulsion showed an increased blood pressure and aortic flow rates relative to the same volume of saline. Additionally, isolated rat hearts in isovolumetric contraction were seen to contract more forcefully, with increased oxygen demand, when perfusate was augmented with lipid emulsion [11] . Stehr and colleagues [12] additionally demonstrated a positive effect on bupivacaine toxic cardiac myocytes at levels below those that could have effected any "sink" phenomenon. The same investigators furthermore modeled the relative contributions of volume, sink and cardiotonic effects in an in silico model for the observed effect on recovery of rats from bupivacaine-induced shock. The model of best fit included all three factors, with the direct cardiotonic effect being the most prominent factor responsible for observed improvement [13] . It seems likely that direct cardiotonic effects play a significant role as one of the mechanisms responsible for resuscitation from drug-induced cardiotoxicity. This may be particularly so in the arrested or critically compromised circulation in order to offer immediate support before any distributive effects are likely to occur.
Metabolism
Lipids comprise the heart's preferred energy substrate under normal aerobic conditions, and it was reasoned that flux through this pathway could directly affect cardiac function. Therefore, an early theory was that a large lipid load could offset the potent inhibition of fatty acid metabolism caused by bupivacaine. Evidence in support of this theory was first published by Stehr et al. [12] who showed that in isolated rat heart, concentrations of lipid too low to substantially reduce bupivacaine content in the perfusate were able to reverse bupivacaine-induced reduction in cardiac function. More recently, Partownavid et al. [14] confirmed a metabolic effect by showing that inhibition of fatty acid oxidation prevents lipid reversal of bupivacaine-induced cardiac toxicity. The lipid infusion was associated with additional cytoprotective effects that suppressed the mitochondrial permeability transition, a key step in programmed cell death. Aside from the reversal of bupivacaine toxicity, we have observed that lipid infusion can exert a direct cardiotonic effect in both intact rats and isolated rat hearts. Although the precise mechanism of this phenomenon is unknown, it occurs very rapidly and might contribute to lipid resuscitation.
Other Mechanisms Direct Inotropy
An alternate theory for ILE's successful reversal of local anesthetic drug toxicity may be related to its ability to increase intracellular Ca concentrations in cardiac myocytes. Studies of cardiac ischemiahave shown that within the myocardium, free fatty acid levels rise in parallel with increasing ionized Ca levels. A study by Huang et al. (1992) proved that long-chain fatty acids are responsible for an increase in ionized Ca levels, most likely by activating the myocardial Ca channels, which results in a dose-dependent increase in the Ca current [15] . Stehr et al. (2007) showed that in live rats, ILE administration did not produce an elevated heart rate, but did increase systolic blood pressure, which may support thetheoretical role of ILE as an inotropic agent [12, 16] .
Clinical use Human trials
Few investigators have studied ILE in human populations. Taftachi and colleagues [17] reported the use of a lipid emulsion preparation in a randomized trial evaluating the effect on conscious state in drug-induced coma. In addition to standard supportive care, 15 patients were given an infusion of 10 ml/kg 10% lipid emulsion. A statistically significant increase in Glasgow Coma Scale (GCS) of 2 points was seen in the ILE group. No reported differences were seen for rates of intubation (the primary powered endpoint) or time to extubation. This study has a number of methodological flaws limiting general isability, including absence of a control solution, and no blinding in acquisition of key study metrics (GCS). Additionally, the study tested a number of endpoints without statistical correction for repeat analysis. Perhaps the greatest contribution of this work is in demonstrating that trials involving ILE in toxicology are feasible. Gil and colleagues [18] evaluated the effect of ILE on glyphosate intoxication. After a positive case report, their institution began treating glyphosate intoxication with ILE along with supportive care from January 2012. A two-tiered approach to ILE administration was taken, with those ingesting less than 100 ml of herbicide thought to be at lesser risk of toxicity and given 20 ml/ hour of 20% lipid emulsion, and those ingesting more than 100 ml of herbicide treated with a load of 500 ml of 20% lipid emulsion over 2 to 3 hours and then maintained on 42 ml/hour for the next 24 hours. Historical controls were taken from the previous 2 years of practice, matched for volume and timing of ingestion. Twenty-two cases and controls were compared, with 13 higher dose intoxicant patients in each group. No hypotension or arrhythmia was seen in the ILE-treated group versus rates of 40.9% (hypotension) and 22.7% (arrhythmia) in the control group. These differences reached statistical significance. The preponderance of hypotension and arrhythmia was seen in controls who ingested higher doses of intoxicant. Additionally, death (one case) and acute kidney injury (three cases) were seen only in the control group, and the rate of respiratory failure was lower in the ILE group (14% versus 32%), although these differences did not reach statistical significance. It is considered most likely that surfactants associated with the herbicide are responsible in large part for toxic action, and the authors postulated some sink mechanism may have been in action to ameliorate toxicity.
Case series
The LIPAEMIC investigators reported 48 cases of use of ILE where details of intoxicant, treatment and outcome were entered into an online registry [19] . Complete capture of all cases treated in contributing centers was unlikely based on declining reporting rates over the time of data collection, meaning that inherent positive publication bias in case reports and series may still have been acting on this dataset. Increases were seen over a short time span in both GCS in cases where lipid was used for altered conscious state (median GCS increasing from 4 to 8 over 30 minutes) and systolic blood pressure in shocked patients (median systolic pressure increasing from 70 to 90 mmHg over 30 minutes). One serious complication (bronchospasm) and two minor adverse effects were recorded. The TOXIC consortium reported a case series of nine buses of ILE from three tertiary referral centers [20] . Indications for use were post-cardiac arrest or refractory shock defined as circulatory compromise requiring the use of more than one vasopressor. Five of the nine patients survived, which was considered a positive outcome for ILE.
Three case series have been reported as conference abstracts. The Washington poisons centre reported five cases of use: bupivacaine toxicity (asystole), and carbamazepine, hydroxychloroquine, flecainide and bupropiontoxicity (seizures and hypotension). All caseswere associated with clinical resolution of acute effects. Kapadia and colleagues [21] reported two cases of tricyclic antidepressant toxicity refractory to maximal therapy including alkalinisation and hypertonic saline whose clinical course improved after ILE. Jovic-Stosic at al. [22] reported a series of nine uses of ILE where the indication for use was poor response to vasopressors in a series of patients intoxicated with a lipophilic toxin. Increases in blood pressure and GCS, reported as occurring in all patients, were not quantified. A decrease in free verapamil concentration was described in one patient after ILE, with this same patient also exhibiting evidence of acute respiratory distress syndrome.
Case reports
Two recent publications have summarized individual cases reported in the literature [25, 26] . Case report data can be instructional in offering insights into therapies, and are particularly useful when outlining an "all or nothing" type clinical situation. The significant limitation of such analyses is that for any effect published-both positive and negative-it is not known how many unpublished cases were treated. The absence of an accurate numerator significantly limits the generalisability of such collections of cases. With this as a major caveat, the review of Waring [23] found that there was improvement in 51 of 76 cases following administration of ILE to treat poisoning (28% of reported cases being LAST, 26% being cardiovascular drugs, 25% psychotropic agents and 11% antiepileptic).
Other Toxicological Emergencies
This publication, along with the above-mentioned animal studies, opened the door to more widespread use of lipid emulsion for emergency treatment of toxicities caused by a range of lipophilic drugs. Notably, published examples now include toxicities related to verapamil, diltiazem, amlodipine, quetiapine and sertraline, haldoperidol, lamotrigine, olanzapine, propranolol, atenolol, nevibolol, doxepin, dosulepin, imipramine, amitriptyline, glyosphate herbicide, flecainide, venlafaxine, moxidectin, and others. It is arguable whether lipid infusion was the proximate cause of toxic reversal in all these singlet case reports. However, it appears lipid might be generally effective in cases where the agent(s) are lipophilic, despite possessing disparate pharmacologic profile infusions. This could apply to treating cases of multi-drug overdose, such as that reported by Harvey et al. [24] . Others have recently found that treatment of such mixed-drug overdose with lipid emulsion resulted in a reduced incidence of intubation and shorter duration of stay in the intensive care unit than matched controls not receiving lipid. Thus the salutary clinical effects of lipid infusion might extend to cost savings as well. Interestingly, the reversal of haldol-induced Torsades occurred in the same hospital where a year earlier the case report of rescue from bupropion overdose occurred. The treating physician was aware of the previous case and therefore ordered the infusion of lipid emulsion after 15 min of failed standard resuscitation. Similarly, Smith et al. [25] reported an apparent save of a patient in cardiac arrest following a bupivacaine-based peripheral nerve block when physicians who had recently attended a simulator course that included a lipid scenario administered the emulsion. These cases emphasize the positive effect that education and awareness of the method can have on patient outcome.
Adverse Effects of Intravenous Lipid Infusion when Used as an Antidote
Several complications have been described with intravenous administration of lipid emulsion. These complications can occur when lipid is given as an antidote, and can be divided into immediate and delayed complications [26] . Immediate complications include pyrogenic reactions and fat overload. Delayed adverse reactions from lipid infusions are more likely to be seen in higher doses, such as would be expected with antidotal use [26] . These complications include acute lung injury and fat accumulation, which can manifest as fat embolism, hemolytic anemia, and hyperlipidemia [27] [28] [29] . Antidotal use of ILE has the potential to cause hypertriglyceridemia [28] ; pancreatitis has only recently been described [29] .
Guidelines on lipid rescue therapy [30] Lipid rescue therapy for the management of cardiac arrest associated with local anaesthetic injection as recommended by the Association of Anaesthetists of Great Britain, ACMT and ARSA Start CPR using standard protocols Manage arrhythmias using the same protocols, recognising that they may be very refractory to treatment Prolonged resuscitation may be necessary; it may be appropriate to consider other options Consider the use of cardiopulmonary bypass if available Consider treatment with intravenous lipid emulsion Treatment of cardiac arrest with lipid emulsion Give an intravenous bolus injection of Intralipid 20% 1.5 ml/kg over 1 min Continue CPR Start an intravenous infusion of Intralipid 20% at 0.25 ml/kg/min Repeat the bolus injection twice at 5-min intervals if adequate circulation has not been restored After another 5 min, increase the rate to 0. 5 
Conclusion
Despite the ever-increasing case report literature of the use of lipid emulsion therapy in poisoning, the absolute indications for its use remain limited. ILE might be considered in severe cardiovascular instability resulting from lipophilic toxin poisoning, in particular if this does not respond to conventional measures. ILE cannot currently be recommended as a therapy for the sole reason of a reduced level of consciousness. Further scientific guidance, in the form of pre-and post-ILE administration serum drug concentrations in individual cases and clinical outcome trials in the general toxicology population will assist greatly in determining the role and effectiveness of ILE therapy in poisoning.
